Cargando…

Anti-inflammatory microenvironment of esophageal adenocarcinomas negatively impacts survival

OBJECTIVE: Reflux promotes esophageal adenocarcinomas (EACs) creating a chronic inflammatory environment. Survival rates are low due to early local recurrences and distant metastasis. Hence, there is a need for new potential treatment options like immunotherapies. However, the inflammatory microenvi...

Descripción completa

Detalles Bibliográficos
Autores principales: Karstens, Karl-Frederick, Kempski, Jan, Giannou, Anastasios D., Pelczar, Penelope, Steglich, Babett, Steurer, Stefan, Freiwald, Eric, Woestemeier, Anna, Konczalla, Leonie, Tachezy, Michael, Reeh, Matthias, Bockhorn, Maximilian, Perez, Daniel, Mann, Oliver, Lohse, Ansgar W., Roesch, Thomas, Izbicki, Jakob R., Gagliani, Nicola, Huber, Samuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7230052/
https://www.ncbi.nlm.nih.gov/pubmed/32100077
http://dx.doi.org/10.1007/s00262-020-02517-8
_version_ 1783534870664839168
author Karstens, Karl-Frederick
Kempski, Jan
Giannou, Anastasios D.
Pelczar, Penelope
Steglich, Babett
Steurer, Stefan
Freiwald, Eric
Woestemeier, Anna
Konczalla, Leonie
Tachezy, Michael
Reeh, Matthias
Bockhorn, Maximilian
Perez, Daniel
Mann, Oliver
Lohse, Ansgar W.
Roesch, Thomas
Izbicki, Jakob R.
Gagliani, Nicola
Huber, Samuel
author_facet Karstens, Karl-Frederick
Kempski, Jan
Giannou, Anastasios D.
Pelczar, Penelope
Steglich, Babett
Steurer, Stefan
Freiwald, Eric
Woestemeier, Anna
Konczalla, Leonie
Tachezy, Michael
Reeh, Matthias
Bockhorn, Maximilian
Perez, Daniel
Mann, Oliver
Lohse, Ansgar W.
Roesch, Thomas
Izbicki, Jakob R.
Gagliani, Nicola
Huber, Samuel
author_sort Karstens, Karl-Frederick
collection PubMed
description OBJECTIVE: Reflux promotes esophageal adenocarcinomas (EACs) creating a chronic inflammatory environment. Survival rates are low due to early local recurrences and distant metastasis. Hence, there is a need for new potential treatment options like immunotherapies. However, the inflammatory microenvironment in EACs and its impact on patient outcome remain to be fully understood. METHODS: mRNA expression levels of pro- and anti-inflammatory markers in 39 EAC patients without neoadjuvant radio-chemotherapy were measured. Data were confirmed using flow cytometric analysis of freshly resected surgical specimens. Inflammatory alterations in premalignant lesions of Barrett’s esophagus were analyzed by immunohistochemistry. RESULTS: Expression levels of IL22 were reduced in EAC, while expression levels of FOXP3, IL10 and CTLA4 were increased. Flow cytometry demonstrated a strong infiltration of CD4(+) T cells with a reduction in CD4(+) T cells producing IL-22 or IL-17A. We also observed an increase in CD4(+)CD127(low)FOXP3(+) cells producing IL-10. Accumulation of FOXP3(+) T cells occurred prior to malignant changes. High expression of IL10 and low expression of IL22 in EAC were associated with reduced overall survival. Moreover, increased expression of IL10, CTLA4 and PD1 in the unaltered esophageal mucosa distant to the EAC was also linked with an unfavorable prognosis. CONCLUSION: EAC shows an anti-inflammatory environment, which strongly affects patient survival. The microscopically unaltered peritumoral tissue shows a similar anti-inflammatory pattern indicating an immunological field effect, which might contribute to early local recurrences despite radical resection. These data suggest that using checkpoint inhibitors targeting anti-inflammatory T cells would be a promising therapeutic strategy in EAC. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00262-020-02517-8) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-7230052
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-72300522020-05-18 Anti-inflammatory microenvironment of esophageal adenocarcinomas negatively impacts survival Karstens, Karl-Frederick Kempski, Jan Giannou, Anastasios D. Pelczar, Penelope Steglich, Babett Steurer, Stefan Freiwald, Eric Woestemeier, Anna Konczalla, Leonie Tachezy, Michael Reeh, Matthias Bockhorn, Maximilian Perez, Daniel Mann, Oliver Lohse, Ansgar W. Roesch, Thomas Izbicki, Jakob R. Gagliani, Nicola Huber, Samuel Cancer Immunol Immunother Original Article OBJECTIVE: Reflux promotes esophageal adenocarcinomas (EACs) creating a chronic inflammatory environment. Survival rates are low due to early local recurrences and distant metastasis. Hence, there is a need for new potential treatment options like immunotherapies. However, the inflammatory microenvironment in EACs and its impact on patient outcome remain to be fully understood. METHODS: mRNA expression levels of pro- and anti-inflammatory markers in 39 EAC patients without neoadjuvant radio-chemotherapy were measured. Data were confirmed using flow cytometric analysis of freshly resected surgical specimens. Inflammatory alterations in premalignant lesions of Barrett’s esophagus were analyzed by immunohistochemistry. RESULTS: Expression levels of IL22 were reduced in EAC, while expression levels of FOXP3, IL10 and CTLA4 were increased. Flow cytometry demonstrated a strong infiltration of CD4(+) T cells with a reduction in CD4(+) T cells producing IL-22 or IL-17A. We also observed an increase in CD4(+)CD127(low)FOXP3(+) cells producing IL-10. Accumulation of FOXP3(+) T cells occurred prior to malignant changes. High expression of IL10 and low expression of IL22 in EAC were associated with reduced overall survival. Moreover, increased expression of IL10, CTLA4 and PD1 in the unaltered esophageal mucosa distant to the EAC was also linked with an unfavorable prognosis. CONCLUSION: EAC shows an anti-inflammatory environment, which strongly affects patient survival. The microscopically unaltered peritumoral tissue shows a similar anti-inflammatory pattern indicating an immunological field effect, which might contribute to early local recurrences despite radical resection. These data suggest that using checkpoint inhibitors targeting anti-inflammatory T cells would be a promising therapeutic strategy in EAC. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00262-020-02517-8) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2020-02-25 2020 /pmc/articles/PMC7230052/ /pubmed/32100077 http://dx.doi.org/10.1007/s00262-020-02517-8 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Original Article
Karstens, Karl-Frederick
Kempski, Jan
Giannou, Anastasios D.
Pelczar, Penelope
Steglich, Babett
Steurer, Stefan
Freiwald, Eric
Woestemeier, Anna
Konczalla, Leonie
Tachezy, Michael
Reeh, Matthias
Bockhorn, Maximilian
Perez, Daniel
Mann, Oliver
Lohse, Ansgar W.
Roesch, Thomas
Izbicki, Jakob R.
Gagliani, Nicola
Huber, Samuel
Anti-inflammatory microenvironment of esophageal adenocarcinomas negatively impacts survival
title Anti-inflammatory microenvironment of esophageal adenocarcinomas negatively impacts survival
title_full Anti-inflammatory microenvironment of esophageal adenocarcinomas negatively impacts survival
title_fullStr Anti-inflammatory microenvironment of esophageal adenocarcinomas negatively impacts survival
title_full_unstemmed Anti-inflammatory microenvironment of esophageal adenocarcinomas negatively impacts survival
title_short Anti-inflammatory microenvironment of esophageal adenocarcinomas negatively impacts survival
title_sort anti-inflammatory microenvironment of esophageal adenocarcinomas negatively impacts survival
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7230052/
https://www.ncbi.nlm.nih.gov/pubmed/32100077
http://dx.doi.org/10.1007/s00262-020-02517-8
work_keys_str_mv AT karstenskarlfrederick antiinflammatorymicroenvironmentofesophagealadenocarcinomasnegativelyimpactssurvival
AT kempskijan antiinflammatorymicroenvironmentofesophagealadenocarcinomasnegativelyimpactssurvival
AT giannouanastasiosd antiinflammatorymicroenvironmentofesophagealadenocarcinomasnegativelyimpactssurvival
AT pelczarpenelope antiinflammatorymicroenvironmentofesophagealadenocarcinomasnegativelyimpactssurvival
AT steglichbabett antiinflammatorymicroenvironmentofesophagealadenocarcinomasnegativelyimpactssurvival
AT steurerstefan antiinflammatorymicroenvironmentofesophagealadenocarcinomasnegativelyimpactssurvival
AT freiwalderic antiinflammatorymicroenvironmentofesophagealadenocarcinomasnegativelyimpactssurvival
AT woestemeieranna antiinflammatorymicroenvironmentofesophagealadenocarcinomasnegativelyimpactssurvival
AT konczallaleonie antiinflammatorymicroenvironmentofesophagealadenocarcinomasnegativelyimpactssurvival
AT tachezymichael antiinflammatorymicroenvironmentofesophagealadenocarcinomasnegativelyimpactssurvival
AT reehmatthias antiinflammatorymicroenvironmentofesophagealadenocarcinomasnegativelyimpactssurvival
AT bockhornmaximilian antiinflammatorymicroenvironmentofesophagealadenocarcinomasnegativelyimpactssurvival
AT perezdaniel antiinflammatorymicroenvironmentofesophagealadenocarcinomasnegativelyimpactssurvival
AT mannoliver antiinflammatorymicroenvironmentofesophagealadenocarcinomasnegativelyimpactssurvival
AT lohseansgarw antiinflammatorymicroenvironmentofesophagealadenocarcinomasnegativelyimpactssurvival
AT roeschthomas antiinflammatorymicroenvironmentofesophagealadenocarcinomasnegativelyimpactssurvival
AT izbickijakobr antiinflammatorymicroenvironmentofesophagealadenocarcinomasnegativelyimpactssurvival
AT gaglianinicola antiinflammatorymicroenvironmentofesophagealadenocarcinomasnegativelyimpactssurvival
AT hubersamuel antiinflammatorymicroenvironmentofesophagealadenocarcinomasnegativelyimpactssurvival